Epilepsy is a condition that many people don't understand. In Japan, researchers wanted to know what people think about it. They made a special test to measure these thoughts and feelings. This test is called the ABLE-J. The test was given to 400 adults in Japan. It started with 29 questions but wa
Bullish, a cryptocurrency exchange, has taken a significant step by filing for an IPO on the NYSE. This move comes as no surprise, given the growing interest in digital assets and the public market's appetite for crypto-related companies. The exchange, led by Tom Farley, a seasoned finance professi
In a significant move, the House of Representatives has approved three bills aimed at regulating the cryptocurrency industry, with one of them now heading to President Donald Trump's desk. The bills are part of Trump's push to establish the U. S. as a global leader in crypto. The first bill, which
The U. S. just took a big step into the future of money. President Donald Trump signed the GENIUS Act into law. This new law sets rules for digital currencies, especially stablecoins. These are digital currencies tied to real things like gold or the U. S. dollar. The goal? To keep their value steady
President Donald Trump has put his signature on a new law that's set to shake up the crypto world. This law, called the GENIUS Act, is all about making sure people feel safe when they're dealing with stablecoins. These are a type of cryptocurrency that's tied to things like the U. S. dollar, so they
Creating secure designs for computer chips is no easy task. It takes a lot of time and effort. Even small mistakes can cause big problems. To tackle this, a new system called CITADEL was created. It's like a building block set for security. You can mix and match different parts to create a strong de
The NFL Players' Association is at a crossroads. The recent resignation of Lloyd Howell has left a big question mark over who will take the reins. Two names are in the running: JC Tretter and Don Davis. Both have strong backing from players, but Tretter seems to have the edge. The process to pick a
In a surprising turn of events, Sarepta Therapeutics has chosen to defy the FDA's request to stop distributing its gene therapy drug, Elevidys. This decision comes after three patient deaths linked to the treatment. The FDA has expressed serious concerns about the safety of the drug and has asked Sa
Florida's warm waters are home to a dangerous bacteria called Vibrio vulnificus. This year, four people have died from infections caused by it. The bacteria loves warm seawater and can enter the body through open wounds or contaminated food, like raw oysters. It's unclear how the recent victims in F
Jenny Fisher, a biology professor at Indiana University Northwest, has been selected for a prestigious fellowship with the U. S. Department of Agriculture (USDA). This program, known as the E. Kika De La Garza science fellowship, aims to boost agricultural opportunities and support Hispanic-Serving
